DRTS
Alpha Tau Medical Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$15.03
+2.80%Next report
Analyst consensus
- Next report date
- Nov 19, 2026
- EPS estimate
- -$0.14
- Revenue estimate
- $368.3K
Latest reported
- Last report date
- Aug 10, 2026
- EPS actual
- -$0.50
- EPS estimate
- -$0.14
- Revenue actual
- $100.0K
- Revenue estimate
- $144.5K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -96.8%
- Revenue beats (12Q)
- 0
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $23
- PT range
- $16 – $30
- Analysts
- 2
2 Buy0 Hold0 Sell
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 19, 2026